(Q41169397)

27 September 2017

title

Addition of etoposide to initial therapy of adult acute lymphoblastic leukemia: a combined clinical and laboratory study (English)

1 reference

27 September 2017

1 reference

lymphoblastic leukemia

1 reference

1

1 reference

27 September 2017

Karp JE

2

1 reference

27 September 2017

Burke PJ

series ordinal

3

1 reference

27 September 2017

Gore SD

series ordinal

4

1 reference

27 September 2017

publication date

1 September 1996

1 reference

27 September 2017

1 reference

27 September 2017

volume

23

1 reference

27 September 2017

issue

1-2

1 reference

27 September 2017

page(s)

71-83

1 reference

The evolving role of etoposide in the management of lymphomas and Hodgkin's disease

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Chronic administration of etoposide in the treatment of non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

High-dose etoposide and marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

DNA topoisomerases: essential enzymes and lethal targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Drug resistance associated with altered DNA topoisomerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Topoisomerase poisons: harnessing the dark side of enzyme mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

High-level expression of MRK 16 and MRK 20 murine monoclonal antibody-define proteins (170,000-180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Failure to detect the P-glycoprotein multidrug resistant phenotype in cases of resistant childhood acute lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Etoposide-induced DNA cleavage in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

The cell biology of multiple drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Etoposide in acute leukemia. Past experience and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Cortisol is transported by the multidrug resistance gene product P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Chronic daily administration of oral etoposide in refractory lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Topoisomerases in human leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

Proliferative Potential of Out-of-cycle Leukaemic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609054804

10.3109/10428199609054804

21 January 2018

Identifiers

DOI

1 reference

27 September 2017

1 reference